J L SCHOUTEN
Overview
Explore the profile of J L SCHOUTEN including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
1713
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haxby J, Gobbini M, Furey M, Ishai A, SCHOUTEN J, Pietrini P
Science
. 2001 Sep;
293(5539):2425-30.
PMID: 11577229
The functional architecture of the object vision pathway in the human brain was investigated using functional magnetic resonance imaging to measure patterns of response in ventral temporal cortex while subjects...
2.
Schmidt M, Oshinsky R, Kim H, SCHOUTEN J, Folley B, Potter W
Psychopharmacology (Berl)
. 1999 Oct;
146(2):119-27.
PMID: 10525746
Rationale: Methods that test for the central effects of alpha(2)-adrenoceptor antagonists can facilitate the clinical development of such compounds. Recently we evaluated the effects of idazoxan (IDX), an alpha(2)-adrenoceptor antagonist...
3.
Ishai A, Ungerleider L, Martin A, SCHOUTEN J, Haxby J
Proc Natl Acad Sci U S A
. 1999 Aug;
96(16):9379-84.
PMID: 10430951
Brain imaging and electrophysiological recording studies in humans have reported discrete cortical regions in posterior ventral temporal cortex that respond preferentially to faces, buildings, and letters. These findings suggest a...
4.
Haxby J, Ungerleider L, Clark V, SCHOUTEN J, Hoffman E, Martin A
Neuron
. 1999 Feb;
22(1):189-99.
PMID: 10027301
The differential effect of stimulus inversion on face and object recognition suggests that inverted faces are processed by mechanisms for the perception of other objects rather than by face perception...
5.
Schmidt M, Risinger R, Hauger R, SCHOUTEN J, Henry M, Potter W
Psychoneuroendocrinology
. 1997 Apr;
22(3):177-88.
PMID: 9203228
Seven male and five female volunteers underwent double-blind infusions of the alpha 2-adrenoceptor antagonist idazoxan (100 and 200 micrograms/mg) and placebo in random order. Blood pressure, plasma norepinephrine, growth hormone...
6.
Schmidt M, Matochik J, Goldstein D, SCHOUTEN J, Zametkin A, Potter W
Neuropsychopharmacology
. 1997 Apr;
16(4):298-310.
PMID: 9094148
alpha 2-Adrenergic receptors modulate the release of several neurotransmitters implicated in the treatment and pathophysiology of mood and anxiety disorders. Significant sex differences occur in the prevalence of both disorders....
7.
Schmidt M, Goldstein D, SCHOUTEN J, Matochik J, Kim H, Potter W
Psychopharmacol Bull
. 1997 Jan;
33(2):253-9.
PMID: 9230639
The sympathetic nervous system can modulate glucose levels through a variety of mechanisms, including inhibition of insulin release by alpha2-adrenergic receptors. Such effects could potentially confound measurements of brain glucose...
8.
Schmidt M, Matochik J, Risinger R, SCHOUTEN J, Zametkin A, Cohen R, et al.
Clin Pharmacol Ther
. 1995 Jun;
57(6):684-95.
PMID: 7781269
Background: Several classes of antidepressant drugs act on alpha 2-adrenergic receptors. Studies of patients with disorders responsive to treatment with these drugs report group differences in ex vivo measures of...
9.